[关键词]
[摘要]
青光眼作为全球首位的不可逆性致盲眼病,其治疗策略始终是眼科领域的研究焦点。以小梁切除术(联合丝裂霉素)及青光眼引流阀植入术为代表的传统术式,因降眼压效果显著,至今仍是青光眼手术的金标准。但此类手术术后并发症发生率较高,且手术前后眼内参数的变化易引发屈光预测偏差,对患者视觉质量造成不利影响。近年来,微创青光眼手术(MIGS)优势凸显,在减少并发症、缩短手术时间、缩小手术切口及促进视力恢复等方面表现突出,且能更好地维持术后屈光稳定。文章系统综述传统青光眼手术与微创青光眼手术对屈光影响的差异,深入探讨其机制与临床应对策略,旨在为青光眼手术的精准屈光管理提供理论依据,最终提升患者视觉质量和生活水平。
[Key word]
[Abstract]
Glaucoma, the leading cause of irreversible blindness worldwide, remains a central focus of ophthalmic research, particularly with regard to surgical management. Conventional procedures, such as trabeculectomy with mitomycin and glaucoma drainage device implantation, continue to be considered the gold standard because of their strong intraocular pressure lowering efficacy. However, these operations are associated with relatively high rates of postoperative complications, and perioperative fluctuations in intraocular parameters can introduce refractive prediction errors that ultimately compromise visual quality. In recent years, minimally invasive glaucoma surgery(MIGS)has gained increasing attention for its advantages in reducing complications, shortening operative time, minimizing incision size, and accelerating visual recovery, while better preserving postoperative refractive stability. This review systematically summarizes the differences in refractive outcomes between conventional surgery and MIGS, examines the underlying mechanisms, and discusses practical clinical strategies to manage refractive shifts. The aim is to provide a theoretical foundation for precise refractive management in glaucoma surgery, thereby enhancing patients' visual quality and overall quality of life.
[中图分类号]
[基金项目]
广西自然科学基金项目(No.2023GXNSFAA026086)